Методы оценки и возможности инструментальной диагностики субклинического атеросклероза коронарных артерий

Субклинический атеросклероз коронарных артерий — частая причина неблагоприятных сердечно-сосудистых событий: инфаркта миокарда, инсульта, внезапной сердечной смерти. В настоящее время существует большой арсенал методов диагностики коронарного атеросклероза. В статье представлены их основные характеристики, преимущества и недостатки, возможности использования в рутинной клинической практике.

1. Herrington W, Lacey B, Sherliker P, et al. Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease. Circ Res. 2016;118(4):535-46. doi:10.1161/CIRCRESAHA.115.307611.

2. Pandya A, Gaziano T, Weinstein M, Cutler D. More americans living longer with cardiovascular disease will increase costs while lowering quality of life. Health Affair. 2013;32(10):1706-14. doi:10.1377/hlthaff.2013.0449.

3. Heris A, Lacer B, Sherlir A, et al. Prevalence of coronary heart disease. Circ Res. 2016;117(5):520-30. doi:10.1161/CIRCRESAHA.

4. Frostegard J. Immunity, atherosclerosis and cardiovascular disease. BMC Med. 2013;11(1):117 doi:10.1186/1741-7015-11-117.

5. Falk E, Shah P, Fuster V. Coronary plaque disruption. Circulation. 1995;(92):657-71. doi:10.1161/01.cir.92.3.657.

6. Goel S, Miller A, Agarwal C, et al. Imaging Modalities to Identity Inflammation in anAtherosclerotic Plaque. Radiol Res Pract. 2015;(14):21-4. doi:10.1155/2015/410967.

7. Viera AJ, Sheridan SL. Global risk of coronary heart disease: assessment and application. Am Fam Physician. 2010;82(3):265-74.

8. Little WC, Applegate RJ. Can arteriography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation. 1988;(78):1157-66.

9. Simon A, Chironi G, Levenson J. Performance of subclinical arterial disease detection as a screening test for coronary heart disease. Hypertension. 2006;(3):392-6.

10. Blankenhorn DH, Curry PJ The accuracy of arteriography and ultrasoundimaging for atherosclerosis measurement: a review. Arch Pathol Lab Med. 1982;106:483-9.

11. Гаврилова Н. Е., Метельская В. А., Перова Н. В. и др. Выбор метода количественной оценки поражения коронарных артерий на основе сравнительного анализа ангиографических шкал. Российский кардиологический журнал. 2014;6:24-29. doi:10.15829/1560-4071-2014-4-108-112.

12. Roberts WC, Jones AA. Quantitation of coronary arterial narrowing at necropsy in sudden coronary death: analysis of 31 patients and comparison with 25 control subjects. Am J Cardiol. 1979;44:39-45.

13. Fleg J, Stone G, Fayad Z, et al. Detection of High-Risk Atherosclerotic Plaque. Report of the NHLBI Working Group on Current Status and Future Directions. 2012;5(9):941-55. doi:10.1016/j.jcmg.2012.07.007.

14. Rioufol G, Finet G, Ginon I, et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation. 2002;106:804-8. doi:10.1161/01.cir.0000025609.13806.31.

15. Кузнецов В.А., Ярославская Е. И. Коронарный атеросклероз: данные Тюменского регистра. Тюмень: ООО “Издательско-полиграфический центр “Экспресс”, 2018:204 с. ISBN 978-5-86093-417-9.

16. Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. Circulation. 2014;129:S1.

17. Muntner P, Colantonio LD, Cushman M, et al. Validation of the atherosclerotic cardiovascular disease pooled cohort risk equations. JAMA. 2014;311:1406-15. doi:10.1001/jama.2014.2630.

18. QRISK2 risk calculator https://qrisk.org (2016). Дата обращения: 23.04.2019.

19. Conroy RM, Pyorala KA, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur. Heart. J. 2003;24:987-1003.

20. Kannel WB, McGee D, Gordon T. A general cardiovascular risk profile: the Framingham Study. Am J Cardiol 1976;38:46-51.

21. Schnabel R. B., Sullivan L. M., Levy D. et al. Development of a Risk Score for Atrial Fibrillation in the Community; The Framingham Heart Study Lancet 2009;373(9665):739-45.

22. Anderson TJ, Gregoire J, Pearson GJ, et al. Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol. 2016;32(11):1263-82. doi:10.1177/1715163517713031.

23. Anderson NV. Intraarterial anayaapal pografiy. J Intern Med. 2012;12(2):23-6. doi:1036.1111/j.1365-2796.2011.02493.

24. Чуян Е.Н., Ананченко М. Н., Трибрат Н. С. Современные биофизические методы исследования процессов микроциркуляции. Ученые записки Таврического национального университета имени В. И. Вернадского. 2009;1:99-112.

25. Erlinge D. Near-infrared spectroscopy for intracoronarydetection of lipid-rich plaques to understand atherosclerotic plaquebiology in man and guide clinical therapy. J Intern Med. 2015;278(2):110-25. doi:10.1111/joim.12381

26. Al-Qaisi M, Nott DM, King DH, Kaddoura S. Ankle brachial pressure index (ABPI): An update for practitioners. Vasc Health Risk Manag. 2009;5:833-41. doi:10.2147/VHRM.S6759.

27. Doobay AV, Anand SS. Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: a systematic review. Arterioscler Thromb Vasc Biol. 2005;25(7):1463-9. doi:10.1161/01.ATV.0000168911.78624.b7.

28. Khan TH, Farooqui FA, Niazi K. Critical review of the ankle brachial index. Curr Cardiol Rev. 2008;4(2):101-6. doi:10.2174/157340308784245810.

29. McDermott MM, Liu K, Criqui MH, et al. Ankle-brachial index and subclinical cardiac and carotid disease: the multi-ethnic study of atherosclerosis. Am J Epidemiol. 2005;162(1):33-41. doi:10.1093/aje/kwi167.

30. Papamichael CM, Lekakis JP, Stamatelopoulos KS, et al. Ankle-brachial index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patients with coronary artery disease. Am J Cardiol. 2000;86(6):615-8. doi:10.1016/S0002-9149(00)01038-9.

31. Kajikawa M, Maruhashi T, Iwamoto Y, et al. Borderline Ankle-Brachial Index Value of 0.91-0.99 Is Associated With Endothelial Dysfunction. CircJ. 2014;78(7):1740-5. doi:10.1253/circj.CJ-14-0165.

32. Tanaka S, Kaneko H, Kano H, et al. The predictive value of the borderline ankle-brachial index for long-term clinical outcomes: An observational cohort study. Atherosclerosis. 2016;250:69-76. doi:10.1016/j.atherosclerosis.2016.05.014.

33. Centers for Disease Control and Prevention (CDC) NCfHSN. National Health and Nutrition Examination Survey Datа (NHANES). https://wwwn.cdc.gov/nchs/nhanes/analyticguidelines.aspx.Accessed (Dec 2017). Дата обращения: 23.04.2019.

34. Васильев А. Ю., Алексахина Т. Ю. Применение спиральной компьютерной томографии в качестве первичного скрининга атеросклеротического кальциноза коронарных артерий. Медицинская практика. 2004;1:40-2.

35. Schader S, Kopp A, Kuettner F, et al. Influence of heart rate on vessel visibility in noninvave coronary angiography using new miltislice computed tomography. Experiencein 94 patients. Clinicalimaging. 2002;26:106-11.

36. Синицын В. Е., Терновой С. К. Новая роль мультиспиральной компьтерной томографии в диагностике болезней сердца и сосудов. Терапевтический архив. 2007;(4):10-11.

37. Budoff MJ, Shaw LJ, Liu ST. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. JACC. 2007;49(18):1860-5.

38. Geluk CA, Dikkers R, Perik PJ. Measurement of coronary calcium scores by electron beam computed tomography or exercise testing as initial diagnostic tool in low-risk patients with suspected coronary artery disease. Eur. Radiol. 2008;8(2):244-52. doi:10.1007/s00330-007-0755-2.

39. Yuan C, Zhang SX, Polissar NL et al. Identification of fibrous cap rupture with magnetic resonance imaging is highly associated with recent transient ischemic attack or stroke. Circulation. 2002;105:181-5. doi:10.1161/hc0202.102121.

40. Yuan C, Mitsumori LM, Beach KW, Maravilla KR. Carotid atherosclerotic plaque: noninvasive MR characterization and identification of vulnerable lesions. Radiology. 2001;(221):285-99. doi:10.1148/radiol.2212001612.

41. Ripa RS, Kjaer A. Imaging atherosclerosis with hybrid positron emission tomography/magnetic resonance imaging. Biomed Res Int. 2015;2015:914516. doi:10.1155/2015/914516.

42. Regar E, Serruys PW. Ten years after introduction of intravascular ultrasound in the catheterization laboratory: tool or toy? 2002;91:89-97.

43. Groves EM, Seto AH, Kern MJ. Invasive Testing for Coronary Artery Disease: FFR, IVUS, OCT, NIRS. Heart Fail Clin. 2016;12(1):83-95. doi:10.1016/j.ccl.2014.04.005.

44. Frimerman A, Miller HI, Siegel RJ, et al. Intravascular ultrasound imaging of myocardial_infarction_related arteries after percutaneous transluminal coronary angioplasty reveals significant plsgue burden and compensatory enlargement. Inter J Cardivasc Intervent. 1999;2:101-7.

45. Mintz GS, Nissen SE, Anderson WD, et al. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. JACC. 2001;37:1478-92.

46. Schaar JA, Korte CL, Mastik F, et al. Characterizing vulnerable plaque features with intravascular elastography. Circulation. 2003;108:2636-41.

47. Taniwaki M. Long-term safety and feasibility of three-vessel multimodality intravascular imaging in patients with ST-elevation myocardial infarction: the IBIS-4 (integrated biomarker and imaging study) substudy. Internat J Cardiovasc Imaging. 2015;31(5):915-26. doi:10.1007/s10554-015-0631-0.